Sotera Health SHC Sterigenics — Total capital expenditures
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sotera Health in its filing.
Tagged under the XBRL concept us-gaap:SegmentExpenditureAdditionToLongLivedAssets.
The official record: Sotera Health’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sotera Health's sterigenics — total capital expenditures.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sotera Health's sterigenics — total capital expenditures?
- Sotera Health (SHC) reported sterigenics — total capital expenditures of $37.89M in Q1 2026.
- How has Sotera Health's sterigenics — total capital expenditures changed year-over-year?
- Sotera Health's sterigenics — total capital expenditures increased by 131.1% year-over-year, from $16.4M to $37.89M.
- What is the long-term trend for Sotera Health's sterigenics — total capital expenditures?
- Over 3 years (2022 to 2025), Sotera Health's sterigenics — total capital expenditures has grown at a -11.6% compound annual growth rate (CAGR), from $144.03M to $99.38M.
- What does sterigenics — total capital expenditures mean?
- The total cash outflows used by the Sterigenics segment to acquire, upgrade, or maintain physical assets such as sterilization facilities and irradiation equipment. This reflects the company's investment in long-term capacity and infrastructure to support future growth.